Level Biotechnology Inc. (TPEX:3118)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.65
+0.05 (0.16%)
Sep 15, 2026, 1:10 PM CST

Level Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
709.37736.59731.35660.61593.01677.28
Revenue Growth
-3.54%0.72%10.71%11.40%-12.44%0.71%
Gross Profit
257.14257.7237.13219.55202.59232.5
Operating Income
85.4183.5575.3267.5564.978.96
Net Income
76.0279.764.8162.9158.4768.18
Earnings Per Share
2.332.441.991.931.792.09
EPS Growth
9.93%22.61%3.11%7.82%-14.35%17.42%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Instrument and Equipment Trading
212.29239.73216.44163.86134.77156.28
Entrusted Biotechnology Service Sales
136.45126.86136.76112.1699.63110.27
Reagent Consumable Materials Trading
360.63370.01378.15384.6358.61410.72
Total
709.37736.59731.35660.61593.01677.28

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
195.38210.34252.78467.41463.5472.96
Total Debt
7.387.9812.6813.4112.5713.18
Net Cash (Debt)
188202.36240.1453.99450.92459.78
Net Cash Growth
-19.67%-15.72%-47.11%0.68%-1.93%26.15%
Net Cash Per Share
5.756.197.3513.9013.8014.08

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
103.959.6164.170.2165.07155.95
Capital Expenditures
-15.31-32.67-223.68-7.67-6.74-9.16
Free Cash Flow
88.626.94-159.5862.5458.33146.8
Free Cash Flow Growth
---7.22%-60.26%81.93%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
36.25%34.98%32.42%33.23%34.16%34.33%
Operating Margin
12.04%11.34%10.30%10.23%10.95%11.66%
Pretax Margin
13.22%13.25%11.09%11.91%12.34%12.53%
Profit Margin
10.72%10.82%8.86%9.52%9.86%10.07%
FCF Margin
12.49%3.66%-21.82%9.47%9.84%21.67%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
2.2002.2001.8001.7001.7001.900
Dividend Per Share Growth
22.22%22.22%5.88%0%-10.53%18.75%
Dividend Yield
6.98%7.13%6.35%6.62%7.70%8.48%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.5813.4416.0215.7115.3514.26
P/FCF Ratio
11.5939.75-15.8015.386.62
PS Ratio
1.451.451.421.501.511.44